And the first company to cross the finish line . . . is, unofficially, Protein Sciences Corp. of Connecticut, according to company CEO Dan Adams. What follows is the press release from AFP:
A US company that was awarded a 35-million-dollar contract
to develop an influenza vaccine using insect cell technology has produced a
first batch against (A)H1N1 flu, company boss Dan Adams said.
From
'On Pharma'
